About lab
Tang2019 - Pharmacology modelling of AURKB and ZAK interaction in TNBC
This Biosimulant lab wraps Tang2019 - Pharmacology modelling of AURKB and ZAK interaction in TNBC as a runnable oncology model with a companion visualization module.
Aurora Kinase B and ZAK interaction model Equivalent of the stochastic model used in 'Network pharmacology model predicts combined Aurora B and ZAK inhibition in MDA-MB-231 breast cancer cells' by Tan. It can be used to explore treatment-response dynamics and compare scenario outcomes across configurations.
What You'll See
The lab asks: How does the bundled treatment-response model evolve under its baseline source conditions? It runs for 10.0 time units with a communication step of 1.0. The run uses the model defaults declared by the curated SBML wrapper. The generated visualizations focus on ATM, SRC, BAD, PTEN, SHC1, and PKN1, combining trajectory, endpoint-comparison, and summary-table views from one completed dark-mode run.
In this captured run, BAD peaked at 38.348 and BAD moved by 37.350 native units across 10.0 simulation windows.
Output Visualizations

Summary table for Tang2019 - Pharmacology modelling of AURKB and ZAK interaction in TNBC, reporting the scientific question, observed answer (largest change: BAD at 37.350 native units), evidence (peak observable: BAD), dominant module, and caveat.

Trajectories of ATM, SRC, BAD, PTEN, SHC1, and PKN1 across the 10.0 simulation. In this run BAD climbed from 1.000 to 38.348 and SRC fell from 1.000 to 0.4010 — the largest movements among the focused observables.

Endpoint ranking of the focused observables. Top 3 by final value: BAD = 38.348, SHC1 = 11.084, PTEN = 4.667, with 3 more observables below.
Model Context
- Core model:
models/core - Visualization model:
models/visualisation - Standard:
other - Upstream source:
biomodels_ebi:BIOMD0000000940 - License:
CC0 - Visual scope: Drug/treatment response and tumour-state change
- Caveat: Values are native SBML quantities; the cleanup does not reinterpret source equations.
Inputs
| Input | Maps To | Default | Notes |
|---|---|---|---|
| Kd tgfbr1 source parameter | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.kd_tgfbr1_level | 0.45 | Kd tgfbr1 source parameter. Maps to bundled SBML parameter kd_tgfbr1. |
| K tgfbr1 source parameter | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.k_tgfbr1_level | 0.5 | K tgfbr1 source parameter. Maps to bundled SBML parameter k_tgfbr1. |
| ATM | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.initial_atm | 1.0 | Initial ATM. Sets the initial value of bundled SBML symbol ATM. |
| SRC | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.initial_src | 1.0 | Initial SRC. Sets the initial value of bundled SBML symbol SRC. |
| BAD | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.initial_bad | 1.0 | Initial BAD. Sets the initial value of bundled SBML symbol BAD. |
| PTEN | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.initial_pten | 1.0 | Initial PTEN. Sets the initial value of bundled SBML symbol PTEN. |
Outputs
| Output | Maps To | Role |
|---|---|---|
atm | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.atm | ATM observable. |
src | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.src | SRC observable. |
bad | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.bad | BAD observable. |
pten | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.pten | PTEN observable. |
shc1 | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.shc1 | SHC1 observable. |
pkn1 | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.pkn1 | PKN1 observable. |
state | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.state | Full raw SBML observable record for reproducibility and downstream visualisation. |
summary | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.summary | Change and peak summary across the simulated SBML observables. |
species_labels | oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.species_labels | Mapping from selected raw SBML observable symbols to display labels. |
Runtime
- Duration:
10.0 - Communication step:
1.0
Running Locally
biosimulant labs serve .
Aurora Kinase B and ZAK interaction model Equivalent of the stochastic model used in 'Network pharmacology model predicts combined Aurora B and ZAK inhibition in MDA-MB-231 breast cancer cells' by Tan. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Runtime
Runs
Metadata
Manifest
{
"io": {
"inputs": [
{
"name": "kd_tgfbr1_source_parameter",
"label": "Kd tgfbr1 source parameter",
"units": "native SBML value",
"default": 0.45,
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.kd_tgfbr1_source_parameter",
"description": "Kd tgfbr1 source parameter. Maps to bundled SBML parameter `kd_tgfbr1`."
},
{
"name": "k_tgfbr1_source_parameter",
"label": "K tgfbr1 source parameter",
"units": "native SBML value",
"default": 0.5,
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.k_tgfbr1_source_parameter",
"description": "K tgfbr1 source parameter. Maps to bundled SBML parameter `k_tgfbr1`."
},
{
"name": "initial_atm",
"label": "ATM",
"units": "native SBML value",
"default": 1,
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.initial_atm",
"description": "Initial ATM. Sets the initial value of bundled SBML symbol `ATM`."
},
{
"name": "initial_src",
"label": "SRC",
"units": "native SBML value",
"default": 1,
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.initial_src",
"description": "Initial SRC. Sets the initial value of bundled SBML symbol `SRC`."
},
{
"name": "initial_bad",
"label": "BAD",
"units": "native SBML value",
"default": 1,
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.initial_bad",
"description": "Initial BAD. Sets the initial value of bundled SBML symbol `BAD`."
},
{
"name": "initial_pten",
"label": "PTEN",
"units": "native SBML value",
"default": 1,
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.initial_pten",
"description": "Initial PTEN. Sets the initial value of bundled SBML symbol `PTEN`."
}
],
"outputs": [
{
"name": "atm",
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.atm",
"description": "ATM observable. Maps to SBML symbol `ATM`."
},
{
"name": "src",
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.src",
"description": "SRC observable. Maps to SBML symbol `SRC`."
},
{
"name": "bad",
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.bad",
"description": "BAD observable. Maps to SBML symbol `BAD`."
},
{
"name": "pten",
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.pten",
"description": "PTEN observable. Maps to SBML symbol `PTEN`."
},
{
"name": "shc1",
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.shc1",
"description": "SHC1 observable. Maps to SBML symbol `SHC1`."
},
{
"name": "pkn1",
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.pkn1",
"description": "PKN1 observable. Maps to SBML symbol `PKN1`."
},
{
"name": "state",
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"oncology",
"pharmacology",
"physiology",
"sbml",
"systemsbiology",
"tumor-growth"
],
"title": "Tang2019 - Pharmacology modelling of AURKB and ZAK interaction in TNBC Lab",
"models": [
{
"path": "owned/models/oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model",
"alias": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model",
"provenance": {
"owned_path": "owned/models/oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model_state"
],
"from": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.state"
},
{
"to": [
"visualisation.oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model_summary"
],
"from": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model_species_labels"
],
"from": "oncology_sbml_tang2019_pharmacology_modelling_of_aurkb_and_zak_biomd0000000940_model.species_labels"
}
],
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"description": "Aurora Kinase B and ZAK interaction model Equivalent of the stochastic model used in 'Network pharmacology model predicts combined Aurora B and ZAK inhibition in MDA-MB-231 breast cancer cells' by Tan. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.